Company Filing History:
Years Active: 2021
Title: The Innovative Mind of Miguel I. Gonzalez
Introduction
Miguel I. Gonzalez, a notable inventor based in Albany, California, is recognized for his contributions to the field of medical applications through innovative materials. With a focus on coordination polymers, he has developed a groundbreaking patent that addresses key issues in drug delivery and therapeutic efficacy.
Latest Patents
Gonzalez holds one patent titled "Metal-olsalazine coordination polymers for medical applications." This invention utilizes olsalazine, a prodrug of the anti-inflammatory 5-aminosalicylic acid, as a ligand to synthesize various metal-olsalazine materials, where metals include Mg, Ca, Sr, Fe, Co, Ni, Cu, and Zn. The polymers described in the patent offer a suite of coordination solids and metal-organic frameworks, featuring unique 1-, 2-, and 3-dimensional structures. These materials exhibit resistance to degradation in acidic environments and release olsalazine preferentially at neutral pH levels, showcasing their potential in drug delivery systems.
Career Highlights
Miguel I. Gonzalez's career has been marked by his association with the University of California, where he focuses on the development of innovative materials for medical applications. His research contributes significantly to the understanding and implementation of coordination chemistry in the medical field, aligning with the advancements in therapeutic delivery systems.
Collaborations
Throughout his career, Gonzalez has collaborated with esteemed colleagues such as Dana J. Levine and Jeffrey R. Long. These partnerships provide a multidisciplinary approach to his research, enhancing the potential applications of his patented innovations in various medical scenarios.
Conclusion
In conclusion, Miguel I. Gonzalez stands out as a pioneering inventor whose work on metal-olsalazine coordination polymers holds promise for advancing drug delivery technologies. His efforts, underscored by collaboration and innovative thinking, contribute significantly to the future of medical applications, paving the way for improved therapeutic outcomes.